Core Scientific has been upgraded to an “Outperform” rating following the unsuccessful merger with CoreWeave, according to Macquarie. This upgrade reflects a shift in market sentiment regarding the company’s future prospects. Analysts at Macquarie have reassessed Core Scientific’s position in light of the merger’s failure, suggesting that the company may have potential for growth despite the setback. The decision to upgrade the rating indicates confidence in Core Scientific’s ability to navigate challenges and capitalize on opportunities moving forward.
